长江生命科技主席李泽巨:生物科技高回报高风险,纯收息买基建或收租股较适合

智通财经
22 May

李泽巨表示,生物科技研究是属于一个高回报、高风险的行业。如果买股票纯粹为收息,可能买基建或收租股较适合。智通财经APP获悉, 长江生命科技 主席李泽巨近日在股东周年大会中表示,生物科技研究是属于一个高回报、高风险的行业。如果研究成功的话,只需一只产品,它的价值有机会可以高过很多上市基建甚至地产公司。如果买股票纯粹为收息,可能买基建或收租股较适合。其认为,如果公司有一个全面性投资组合,将一部分资金...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10